MIG
MIG is a leading German VC investor, focussed on early to mid-stage technology and life science companies.
Business Model: B2B
Revenue: $15.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed MIG Information
Geographic Data
Address: Ismaninger Straße 102
City: Munich
State: bavaria
Zip: 81675
Country: DE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
2,884,672Website Global Rank
5,863Website Monthly Traffic
Twitter Followers
Description
MIG Verwaltungs AG (MIG AG) is one of the leading German VC Investors. MIG invests in deep technology from early to later stage. MIG Verwaltungs AG (MIG AG) uses investments to shape a better tomorrow, today. They manage MIG Fonds, funds used to finance entrepreneurs and start-up businesses in various stages of development. As a venture capital investor, they have already funnelled nearly 500 million Euro into start-up ventures and as such have helped more than 30 outstanding business ideas become a reality. MIG currently manages 16 MIG public venture funds regulated by BAFIN with a total of 1.0 bn Euro of committed capital from more than 50.000 private investors. MIG is currently invested in a portfolio of 26 companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2021 | Efficient Energy | Series A | 11.8M |
| 3/2011 | AMSilk | Series B | 7.1M |
| 4/2013 | Efficient Energy | Venture Round | 17.6M |
| 5/2009 | Sovicell GmbH | Venture Round | - |
| 6/2011 | Cynora | Series A | 6.6M |
| 4/2017 | LXP Group GmbH | Series A | 2.8M |
| 1/2012 | NFON | Venture Round | 5.2M |
| 4/2010 | IDENT Technology | Venture Round | 338k |
| 4/2012 | Siltectra | Seed Round | 1.6M |
| 5/2013 | SuppreMol | Series D | 12.3M |
| 4/2016 | Siltectra | Series B | 1.7M |
| 11/2007 | Isarna Therapeutics | Venture Round | 39.6M |
| 9/2019 | Biocrates Life Sciences | Venture Round | - |
| 8/2009 | Protagen | Venture Round | 5.3M |
| 1/2014 | Isarna Therapeutics | Venture Round | 17.8M |
| 6/2018 | Efficient Energy | Venture Round | 7.7M |
| 6/2015 | Efficient Energy | Venture Round | 13.4M |
| 3/2011 | Efficient Energy | Venture Round | 10.2M |
| 3/2010 | Biocrates Life Sciences | Venture Round | 1.6M |
| 12/2017 | Siltectra | Series B | 4.6M |
| 2/2016 | Hemovent | Series A | 6M |
| 3/2007 | Sovicell GmbH | Series D | 1.2M |
| 3/2021 | Bolt | Venture Round | 0 |
| 4/2013 | Siltectra | Series A | 2.2M |
| 6/2014 | Siltectra | Series A | 1M |
| 8/2008 | Protagen | Venture Round | - |
| 7/2019 | IQM Quantum Computers | Seed Round | 0 |
| 9/2008 | Corimmun | Series A | 7.2M |
| 5/2015 | Siltectra | Series B | 1.7M |
| 9/2021 | KEWAZO | Series A | 0 |
| 4/2016 | KONUX | Series A | 0 |
| 10/2010 | Corimmun | Series B | 10.4M |
| 1/2020 | KEWAZO | Seed Round | 2.8M |
| 2/2019 | KONUX | Series B | 13M |
| 3/2019 | Liva Healthcare | Series A | 9M |
| 12/2020 | German Bionic | Series A | 0 |
| 4/2018 | KONUX | Series B | 20M |
| 9/2011 | IDENT Technology | Venture Round | - |
| 5/2021 | AMSilk | Series C | 0 |
| 6/2016 | AFFiRiS | Venture Round | 10M |
| 7/2008 | SuppreMol | Series B | 25M |
| 5/2018 | advanceCOR | Venture Round | 7.1M |
| 11/2020 | Innatera Nanosystems | Seed Round | 0 |
| 6/2006 | Biocrates Life Sciences | Series A | 6.3M |
| 4/2018 | KEWAZO | Seed Round | 1.3M |
| 10/2021 | IOmx Therapeutics | Series B | 0 |
| 9/2010 | immatics biotechnologies | Series C | 71.2M |
| 3/2023 | talpasolutions | Series B | 0 |
| 8/2018 | GWA Hygiene | Venture Round | 2.8M |
| 4/2017 | AFFiRiS | Venture Round | 10.9M |
| 11/2011 | AFFiRiS | Venture Round | 33.9M |
| 3/2010 | Isarna Therapeutics | Venture Round | 0 |
| 3/2017 | Siltectra | Series B | 2.8M |
| 7/2011 | Isarna Therapeutics | Venture Round | 0 |
| 3/2017 | KONUX | Series A | 9M |
| 9/2012 | SuppreMol | Series D | 8.2M |
| 4/2023 | AMSilk | Series C | 0 |
| 3/2022 | InBolt | Seed Round | 3.3M |
| 12/2014 | Protagen | Venture Round | 12.3M |
| 6/2016 | Cynora | Series A | 25M |
| 7/2017 | Hemovent | Series A | 2.3M |
| 12/2015 | NavVis | Series B | 8.2M |
| 11/2013 | Ganymed Pharmaceuticals | Series E | 0 |
| 1/2018 | BioNTech | Series A | 270M |
| 12/2018 | NavVis | Series C | 35.5M |
| 4/2014 | Isarna Therapeutics | Venture Round | 0 |
| 1/2023 | KEWAZO | Series A | 0 |
| 12/2005 | Isarna Therapeutics | Private Equity Round | 0 |
| 12/2010 | SuppreMol | Series C | 20.4M |
| 12/2021 | NavVis | Venture Round | 0 |
| 11/2021 | Bolt | Series B | 0 |
| 3/2019 | Efficient Energy | Venture Round | 8.3M |
| 5/2017 | Efficient Energy | Venture Round | 5.6M |
| 11/2008 | Efficient Energy | Seed Round | 5.1M |
| 1/2021 | Liva Healthcare | Series B | 0 |
| 3/2020 | Efficient Energy | Venture Round | 0 |
| 11/2008 | Ganymed Pharmaceuticals | Series D | 81.8M |
| 1/2008 | Protagen | Venture Round | 1.5M |
| 11/2014 | NavVis | Series A | 1.9M |
| 5/2006 | Protagen | Series B | 4.2M |
| 2/2010 | PDC Biotech | Series A | 5.5M |
| 12/2021 | NavVis | Venture Round | 0 |
| 11/2021 | Bolt | Series B | 0 |
| 10/2021 | IOmx Therapeutics | Series B | 0 |
| 9/2021 | KEWAZO | Series A | 0 |
| 5/2021 | AMSilk | Series C | 0 |
| 3/2021 | Bolt | Venture Round | 0 |
| 1/2021 | Liva Healthcare | Series B | 0 |
| 12/2020 | German Bionic | Series A | 0 |
| 11/2020 | Innatera Nanosystems | Seed Round | 0 |
| 3/2020 | Efficient Energy | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
